Home
Scholarly Works
S3 Gefapixant efficacy and safety in participants...
Conference

S3 Gefapixant efficacy and safety in participants with history of refractory or unexplained chronic cough for ≥1 vs <1 year

Authors

Smith J; Satia I; Birring S; McGarvey L; Lu S; Martin Nguyen A; Xu J; Reyfman P; Urdaneta E; Philip G

Pagination

pp. a6-a6

Publisher

BMJ

Publication Date

November 1, 2023

DOI

10.1136/thorax-2023-btsabstracts.9

Name of conference

‘The drugs do work!’ – New treatments in cough
View published work (Non-McMaster Users)

Contact the Experts team